• Skip to main content

DistilGovHealth

DistilNFO GovHealth Advisory

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Breakthrough stem cell treatment ‘cures’ HIV man

Share:

March 19, 2019

Ten years ago, a Berlin patient allegedly ‘beat’ HIV/AIDs; going into remission after receiving a bone-marrow transplant from a donor with natural immunity to the virus.

Now, a male London patient on treatment for cancer has been HIV ‘free’ for over a year. He had undergone chemotherapy and also had stem cells implanted, leading to both his cancer and HIV going into remission. Researchers from University College London, Imperial College London, Cambridge and Oxford Universities were all involved in the case, but say it is too early to claim a complete ‘cure’ of HIV.

Prof. Ravindra Gupta from UCL has remarked that the Berlin patient was not an anomaly because the same treatment approaches eliminated HIV in two people. But Prof. Eduardo Olavarria of ICL has cautioned that the treatment used was not an appropriate standard HIV treatment because of the toxicity of chemotherapy.

Dr. Andrew Freedman from Cardiff University has also said that this type of treatment is not practical. Freedman has instead encouraged prompt diagnosis and starting early on lifelong combination antiretroviral therapy to prevent transmission of the virus, allowing for a near-normal life expectancy for HIV patients.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

In HIV/AIDs, CCR5 is the most common receptor by which the virus enters cells. A minority of people have two mutated copies of the CCR5 receptor, where the virus cannot penetrate cells in the body it normally infects.The London patient received donor stem cells with this specific mutation, which made him resistant to HIV. Hence, it is possible to use gene therapy to target the CCR5 receptor.

Prof. Graham Cooke of ICL’s National Institute for Health Research has said that better understanding of why the procedure works in some patients and not others will bring experts closer to the ultimate goal of curing HIV.

Current HIV therapies are effective, so the discovery does not offer new treatment options, but could help in new ways to tackle the disease and achieve a cure.

Date: March 20, 2019

Source: HealthcareAsia Daily

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Major Payers Find HHS Finalized Nondiscrimination Rule Too NarrowMajor Payers Find HHS Finalized Nondiscrimination Rule Too Narrow
  • New Clinically Validated Sleepcheck App LaunchesNew Clinically Validated Sleepcheck App Launches
  • Apple Still has a Lot of Room to Grow in the $3.5 Trillion Health Care SectorApple Still has a Lot of Room to Grow in the $3.5 Trillion Health Care Sector
  • Google Moves Further Into Healthcare: a Timeline of the Last YearGoogle Moves Further Into Healthcare: a Timeline of the Last Year
  • Superb Healthcare At Ultra-Low Prices? How Singapore Does ItSuperb Healthcare At Ultra-Low Prices? How Singapore Does It
  • AI, Machine Learning, and Blockchain are Key for Healthcare InnovationAI, Machine Learning, and Blockchain are Key for Healthcare Innovation

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications